U.S. pharmaceutical giant Bristol Myers Squibb is significantly expanding its research and development operations in India. The company aims to make its newly inaugurated $100 million facility in Hyderabad its largest R&D center outside of the United States by 2025. The Hyderabad site, which was officially opened by CEO Christopher...
GSK Partners with India's Syngene for R&D
U.K.-based pharmaceutical company GlaxoSmithKline, popularly known as GSK, signed an R&D agreement with Syngene International, a global contract research services company based in Bangalore, India. The multi-year agreement will focus on accelerating the discovery of new drug candidates with the potential to address some of the world’s most pressing healthcare needs....